Answer
Application site reactions and breast pain occurred in more than 10% of patients in the clinical trials described for Sandrena estradiol gel.
Sources for this answer
- Sandrena 1.0 mg gelOrion Pharma (UK) Limited · emc · SmPC §4.8 Undesirable effects · Version 20Document updated
Sources checked